Surmodics' (SRDX) "Neutral" Rating Reiterated at Sidoti

Sidoti reiterated their neutral rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a $43.00 target price on the stock. SRDX has been the topic of a number of other reports. Needham & Company LLC reaffirmed a hold rating on […]

Related Keywords

Los Angeles , California , United States , , Los Angeles Capital Management , Barrington Research , Moody National Bank Trust Division , Acadian Asset Management , Sg Americas Securities , Vanguard Group Inc , Needham Company , Surmodics Inc , Free Report , Stock Down , Get Free Report , Angeles Capital Management , Asset Management , National Bank Trust Division , Medical Device , Vitro Diagnostics , Surmodics Daily ,